Yerres, France

Laurent Thibaut

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Laurent Thibaut

Introduction

Laurent Thibaut is a notable inventor based in Yerres, France. He has made significant contributions to the field of biochemistry, particularly in the development of tetracycline compounds. His work focuses on innovative methods to inhibit specific enzyme activities that are associated with various disorders.

Latest Patents

Thibaut holds a patent for "Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors." This invention is directed towards tetracycline compositions and methods of inhibiting Tdp1 activity. It also includes methods for treating Tdp1-associated disorders. His innovative approach has the potential to impact therapeutic strategies significantly.

Career Highlights

Laurent Thibaut has worked with the United States of America, as represented by the Secretary, Department of Health and Human Services. His career reflects a commitment to advancing medical science through innovative research and development.

Collaborations

Thibaut has collaborated with esteemed colleagues such as Yves Pommier and Christophe Marchand. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Laurent Thibaut's contributions to the field of biochemistry through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…